Cleared Traditional

K251577 - LAIA XR (FDA 510(k) Clearance)

Feb 2026
Decision
260d
Days
Class 2
Risk

K251577 is an FDA 510(k) clearance for the LAIA XR. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Augmented Reality Software S.L. (Salamanca, ES). The FDA issued a Cleared decision on February 6, 2026, 260 days after receiving the submission on May 22, 2025.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K251577 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 22, 2025
Decision Date February 06, 2026
Days to Decision 260 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050